Green Arrow Capital Management’s Novartis NVS Stock Holding History

Green Arrow Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-22,320	Closed	-$1.88M	–	163
2014 Q3	$1.88M	Buy	+22,320	New	+$1.81M	0.16%	120
2014 Q2	–	Sell	-61,380	Closed	-$4.68M	–	231
2014 Q1	$4.68M	Sell	61,380 -27,900	-31%	-$2.03M	0.4%	87
2013 Q4	$6.43M	Buy	+89,280	New	+$6.21M	0.45%	75
2013 Q3	–	Sell	-111,600	Closed	-$7.07M	–	291
2013 Q2	$7.07M	Buy	+111,600	New	+$7.26M	0.57%	43

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Green Arrow Capital Management's NVS Position: Q4 2014 in Review

Green Arrow Capital Management sold out of Novartis (NVS) in Q4 2014, closing a stake of 22,320 shares — an estimated $1.88M sold.

Green Arrow Capital Management first reported a position in NVS in Q2 2013 and held it in 4 quarters. The position peaked at $7.07M in Q2 2013. 919 funds tracked by Wall St. Rank hold NVS as of Q4 2014.

Green Arrow Capital Management reported no remaining Novartis position as of Q4 2014 after selling out during the quarter.
Green Arrow Capital Management sold 22,320 Novartis shares in Q4 2014, an estimated $1.88M.
Green Arrow Capital Management first reported a position in Novartis in Q2 2013 and held it in 4 quarters.
Green Arrow Capital Management's Novartis position peaked at $7.07M in Q2 2013.
919 funds tracked by Wall St. Rank held Novartis as of Q4 2014.

Based on Green Arrow Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.